These data reveal an interconnected relationship among inflammation, oxidative stress, TLR9 activation, the release of antiangiogenic factors, and trophoblast dysfunction [83,244,245,248,249,250] and reiterate the complex interplay between many molecular mediators in women with preeclampsia. The gene discussed is TLR9; the disease is preeclampsia.